The Phenotype and Clinical Course of Pediatric Crohn's Disease With Granulomas: A Retrospective Cohort Study

Bilge S Akkelle1, Pinar Ay2, Cigdem Celikel3

  • 1Division of Pediatric Gastroenterology, Hepatology and Nutrition, Marmara University School of Medicine, Istanbul, Turkey.

Insights

Granulomas in pediatric Crohn's disease (CD) indicate a more extensive disease phenotype and are linked to a more aggressive clinical course, including earlier exacerbations and increased risk of fistulizing perianal disease.

Area of Science:

  • Pediatric Gastroenterology
  • Gastrointestinal Pathology
  • Inflammatory Bowel Disease Research

Background:

  • The clinical significance of granulomas in pediatric-onset Crohn's disease (CD) remains unclear.
  • Understanding granuloma's role is crucial for predicting disease course and optimizing treatment in young CD patients.

Purpose of the Study:

  • To investigate the association between granulomas and the phenotype of pediatric CD.
  • To analyze the clinical course and long-term outcomes in pediatric CD patients with and without granulomas.

Main Methods:

  • Retrospective analysis of histopathological findings from 317 endoscopic procedures in 81 pediatric CD patients.
  • Comparison of disease phenotype and clinical follow-up data between patients with and without granulomas detected in biopsies.

Main Results:

  • Granulomas were present in 39.5% of pediatric CD patients at diagnosis.
  • Granuloma presence correlated with ileocolonic disease, upper GI involvement, and moderate-severe disease activity.
  • Granulomas were associated with earlier exacerbations and a higher incidence of fistulizing perianal disease.

Conclusions:

  • Granulomas in pediatric CD are linked to a distinct, extensive disease phenotype.
  • Granulomas may serve as a predictor of aggressive disease progression in pediatric CD.
  • The presence of granulomas could influence treatment strategies for pediatric Crohn's disease.
Abstract

Related Concept Videos

Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
908
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
780
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
703
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.6K
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
75
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The...
64